1. Home
  2. Directory
  3. Montana
  4. Great Falls
  5. Podiatrist
  6. NPI Profile
  7. Prescriptions 1417920521

DR. BRUCE D FISHER D.P.M.
Prescription History 1417920521
Podiatrist in Great Falls, MT


Quality Rating: 0 out of 100 score

NPI Status: Active since February 09, 2006

Contact Information

1016 9TH ST S
GREAT FALLS, MT
ZIP 59405
Phone: (406) 262-3462
Fax: (406) 771-6575

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. BRUCE D FISHER D.P.M., an active Podiatrist specialist practicing in Great Falls, MT. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 347 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 142 claims alone.

Medication Index

Allopurinol

Generic Formulation: AllopurinolSpecialty: Podiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 28.0
Days Supply 820
MT State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills112.6
Peer Average Days Supply3,308
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 72.9% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $126.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.73

State Avg Cost Per Claim

$12.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.

Therapeutic Applications

Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

Doxycycline Monohydrate

Generic Formulation: Doxycycline MonohydrateSpecialty: Podiatry
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 318
MT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply473
Conservative Utilization

This provider writes prescriptions for this formulation 30.4% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $580.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.28

State Avg Cost Per Claim

$24.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.

Therapeutic Applications

This medication is used to treat a certain type of skin condition called rosacea. It helps to reduce the number of pimples and bumps on the face, but it may not decrease redness. It works by reducing skin inflammation caused by rosacea. Although doxycycline belongs to the class of antibiotics known as tetracyclines, this product does not work as an antibiotic because it does not stop the growth of bacteria. Do not use this product to treat any infection, including viral infections (such as the common cold, flu). Use this medication only as prescribed by your doctor.

Gabapentin

Generic Formulation: GabapentinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 142
30-Day Fills 151.0
Days Supply 4,463
MT State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills120.3
Peer Average Days Supply3,396
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 84.4% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,075.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.62

State Avg Cost Per Claim

$17.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Prednisone

Generic Formulation: PrednisoneSpecialty: Podiatry
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 156
MT State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills47.3
Peer Average Days Supply936
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.5% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $79.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.33

State Avg Cost Per Claim

$6.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Pregabalin

Generic Formulation: PregabalinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 98
30-Day Fills 106.5
Days Supply 2,713
MT State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills43.8
Peer Average Days Supply1,230
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 188.2% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,271.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.97

State Avg Cost Per Claim

$36.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Terbinafine Hcl

Generic Formulation: Terbinafine HclSpecialty: Podiatry
Provider Metrics Summary
Total Claims 16
30-Day Fills 25.8
Days Supply 744
MT State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills28.1
Peer Average Days Supply799
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $336.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.02

State Avg Cost Per Claim

$14.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Terbinafine is used to treat certain types of fungal infections (for example, of the fingernail or toenail). It works by stopping the growth of fungus. This medication belongs to a class of drugs known as antifungals.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Podiatry
Provider Metrics Summary
Total Claims 47
30-Day Fills 47.0
Days Supply 200
MT State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills45.8
Peer Average Days Supply927
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $105.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.24

State Avg Cost Per Claim

$6.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. BRUCE D FISHER D.P.M. provides transparency into local medical care patterns within Great Falls, MT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Podiatrist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.